Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
about
A Temporal Model of Human IgE and IgG Antibody FunctionCurrent Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionStructural insights on the role of antibodies in HIV-1 vaccine and therapyResolve, revise, and relax: the 3 Rs of B cell repertoire adjustmentHIV-1 neutralizing antibodies: understanding nature's pathwaysAntibodies in HIV-1 vaccine development and therapyHow specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depthMixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvantsModeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosaHigh affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticityStructural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsCo-evolution of a broadly neutralizing HIV-1 antibody and founder virusSequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingCross-neutralization of influenza A viruses mediated by a single antibody loopComplex-type N-glycan recognition by potent broadly neutralizing HIV antibodiesA gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen RecognitionStructural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodySomatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 NeutralizationReverse vaccinology 2.0: Human immunology instructs vaccine antigen designGlobal shape and ligand binding efficiency of the HIV-1-neutralizing antibodies differ from those of antibodies that cannot neutralize HIV-1Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env GeneBroad neutralization coverage of HIV by multiple highly potent antibodiesHumanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challengeImmune history profoundly affects broadly protective B cell responses to influenza.Defining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.Aggregate complexes of HIV-1 induced by multimeric antibodies.Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasionSomatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemiaAssessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemiaCoexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerA cryptic polyreactive antibody recognizes distinct clades of HIV-1 glycoprotein 120 by an identical binding mechanismImpact of Antigen Density on the Binding Mechanism of IgG Antibodies"Rational vaccine design" for HIV should take into account the adaptive potential of polyreactive antibodies.Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination.Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses.Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.AIDS/HIV. Host controls of HIV neutralizing antibodies.Central B-cell tolerance: where selection begins.B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
P2860
Q21131207-093CB099-27CC-484B-B58B-8CE10A65B5D0Q26775082-30979F14-D929-42A7-922F-665C51C95E68Q26829461-4DB7321B-1EBD-44BE-9556-7E55352D0137Q26852927-BECCC74C-06F0-437E-9A57-1ABD159A4107Q27000480-712A851C-EB13-469C-9688-3847118E92CDQ27011574-FD74E18B-1084-4B2A-8D42-214CB0ED76A1Q27026728-4D3652ED-3B9A-47B6-B4BC-717008D7C479Q27304735-FBB1BF31-4674-4AB3-B3B6-CC21A4FE6418Q27322437-46992E93-B83D-4F65-8AEE-8C8FE0A3CFEFQ27349722-5FCB2718-A4A9-436D-A66C-07DD51EA8D21Q27643993-F3C4C5BD-5B98-4812-8410-F0D2BD642B25Q27644501-0089925F-3A9F-4828-98F6-018EE8146D7EQ27670829-7B7A26D1-16DC-4B1C-AD8E-6CD02001FDEBQ27673206-1EF1CC99-1FE5-4501-B301-18AAA5421141Q27674878-BBD76B65-408D-4E6B-A6B2-CE86A4C7D50CQ27676864-A0777E98-5FC8-41FB-AE83-273FB0B88833Q27677011-E389842F-5C33-481D-9860-D72037F198B0Q27677117-0209D1A3-3B86-4F04-B2F9-5CF1E16B08D1Q28075274-A96B3B72-DF63-4D55-9D6B-7CB58D503B1BQ28250040-A47C6BFD-F5A7-4D56-83A3-E31C80E44F92Q28554907-A1B944AB-3831-4024-AEFC-36E73C3E4171Q29615361-2802EA79-28EE-4726-A07E-5ACE329E2F52Q30234773-725851C7-D340-43D2-BB7C-6232FC78AA3AQ30354064-C148B56B-1992-4936-89D8-A1457D0DB559Q30382131-12D7EFBC-EC89-49AC-8309-076239CA2FEDQ30410411-CE36A047-940D-4D41-BB8F-937268E685B8Q30428633-AD754943-2204-4415-AF4E-24DA603E4BE7Q33595754-125E52A9-FBE2-43E9-949D-9D7F484F102CQ33634440-46C2C7B4-4EBF-491B-887A-7D696B59ADE4Q33766292-F2131919-8C7F-460F-9AE5-BB027DF27667Q33786447-EF8F5379-AF1F-4823-B904-4E6D9A3C71B2Q33793007-176E3D4A-7903-42DA-A143-7B3BE00BEDB2Q33812798-B1090D12-D747-45DB-9667-B6324FF7D2FFQ33941047-712925C3-C654-42CB-BEE7-5768D273D3A6Q34022578-C626523E-7186-465F-859E-50495BB07AFAQ34023249-D095084E-A740-4E6B-BE74-7D0E4C818230Q34042758-15458305-D74C-4F75-BC21-F64EA8496134Q34170264-F10081AB-95BA-4F59-93D7-E9D09108D108Q34257793-22481EB8-744A-400D-A119-B10ACA509BCCQ34273373-79005E5B-8F9B-4953-B657-FB1C4FAF3A6C
P2860
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
@en
type
label
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
@en
prefLabel
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
@en
P2093
P2860
P50
P356
P1433
P1476
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
@en
P2093
Arup K Chakraborty
David D Ho
Hedda Wardemann
Herman N Eisen
Hugo Mouquet
Jeffrey V Ravetch
Johannes F Scheid
John Pietzsch
Mark Connors
Markus J Zoller
P2860
P2888
P304
P356
10.1038/NATURE09385
P407
P577
2010-09-01T00:00:00Z
P5875
P6179
1033805072